Former Apple CEO John Sculley sees big shifts in the ad tech industry, as marketing becomes more personalized. And as smaller companies look to survive, he says they’re turning to Zeta Global, which he co-founded ten years ago.
“There’s so many companies that are for sale because they are too small to be able to compete in the mainstream,” he told Cheddar Monday. “We’ve been constantly approached by companies wanting us to acquire them.”
Just last week, the marketing cloud company bought Disqus, which powers the comment section of websites like TMZ and The Atlantic, services over 4 million websites, and hosts 2 billion monthly unique users.
Sculley also commented on the state of digital advertising, which has been largely dominated by Facebook and Google. He says customers want to broaden their advertising options.
“People want to see other alternatives in addition to Google and Facebook,” he said. “And it’s why you see companies like Zeta Global, and Adobe, and Salesforce.com, and others enjoying so much attention. You have to build out a broader platform.”
Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.
Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.
The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.
Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.
JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
